Terns Pharmaceuticals, Inc. (TERN)

37.18 +2.73 (+7.92%) USD  |  NASDAQ  |  Jan 14, 16:00
37.91 +0.73 (+1.96%) After-Hours: 20:00
More

Terns Pharmaceuticals Total Expenses (% of Annual Revenues)

Total Expenses (% of Annual Revenues) Chart

View Total Expenses (% of Annual Revenues) for TERN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Expenses (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Expenses (% of Annual Revenues) Range, Past 5 Years

View Total Expenses (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Expenses (% of Annual Revenues) Benchmarks

View Total Expenses (% of Annual Revenues) Benchmarks
Start Trial
Altimmune, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade
Viking Therapeutics, Inc. --
Cidara Therapeutics, Inc. Upgrade